| abstract |
Polypeptides and proteins capable of specifically binding to and immunologically recognizing B-cell maturation antigen (BCMA) are disclosed. Also disclosed are chimeric antigen receptors (CARs), anti-BCMA binding moieties, nucleic acids, recombinant expression vectors, host cells, cell populations, pharmaceutical compositions and conjugates related to the polypeptides and proteins. Also disclosed are methods of detecting the presence of cancer and methods of treating or preventing cancer. |